A GLP-1 blocker acts by inhibiting the GLP-1 receptor, which modulates the downstream inflammatory pathways linked to: cytokine production immune system activation oxidative stress inflammatory signaling in tissues such as the liver, fat cells, and gut In low doses, blocking GLP-1 receptors appears to influence the immune system without significantly interfering with glucose control which is why this approach is being studied specifically for inflammation rather than metabolic disease
Add 2 mL of bacteriostatic water to the 10 mg vial
Potential side effects that may be discussed during consultation include: Not every patient experiences side effects
Typical injection sites include the abdomen (avoiding the navel area), outer thigh, and upper arm
Repeat: 30 days on, 30 days off, repeat the structure
BPC-157 10mg BPC-157 Overview BPC-157 (Body Protection Compound-157) is a synthetic peptide consisting of 15 amino acids derived from a protective protein sequence found within human gastric juice